Muhammad Azam Kakar

Muhammad Azam Kakar

Auto-generated profile, based on publicly available information

Muhammad Azam Kakar

Director Planning and Development, L&DD Department, Quetta, Balochistan, Pakistan

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
PSPouya Saraei
Pouya Saraei
IAIlia Asadi
Ilia Asadi
MKMuhammad Azam Kakar
Muhammad Azam Kakar
Nasrollah MoradikorNasrollah Moradikor
Nasrollah Moradikor
Metformin is a widely used drug in today’s prescriptions by physicians due to its specific effects in treating and curing type II diabetes. Diabetes is a common disease that may occur throughout human life, and can increase the likelihood of the occurrence of various types of cancer, such as colon, rectum, pancreas and liver cancers, compared to non-diabetic patients. Metformin inhibits mTOR activity by activating ATM (ataxia telangiectasia mutated) and LKB1 (liver kinase B1) and then adenosine monophosphate-activated kinase(AMPK), and thus prevents protein synthesis and cell growth. Metformin can activate p53 by activatingAMPK and thereby ultimately stop the cell cycle. Given the potential of metformin in the treatment of cancer, it can be used in radiotherapy, chemotherapy and to improve the response to treatment inandrogen derivatives (ADT), and also, according to available evidence, metformin can also be used to prevent various types of cancers. Generally, metformin can: 1) reduce the incidence of cancers, 2) reduce the mortality from cancers, 3) increase the response to treatment in cancer cells when using radiotherapy and chemotherapy, 4) optimize tumor movement and reduce the malignancy, 5) reduce the likelihood of relapse, and 6) reduce the damaging effects of ADT. Therefore, this drug can be used as a complementary therapeutic agent for cancer treatment and prevention. In this review, we have summarized the data from various experimental and clinical studies and highlight the possible potential effects of metformin on cancer therapeutic responses.

30 November 2017 in GMJ Medicine
Verified
Journal Article
Open access
PDF file
BMBehzad Mesbahzadeh
Behzad Mesbahzadeh
MGMahshid Garmsiri
Mahshid Garmsiri
FJFaranak Jalalvand
Faranak Jalalvand
LSLayla Shojaie
Layla Shojaie
MKMuhammad Azam Kakar
Muhammad Azam Kakar
Background: Polycystic ovarian syndrome (PCOS) has been related to dyslipidemia and suppression of antioxidant status. Howeverl, novel agents such as menthol can be an efficient strategy for alleviation of PCOS. This study was conducted to evaluate the effects of different levels of menthol in blood biochemical parameters and antioxidant status ...